Clinical Trials Logo

Pancreas Tumor clinical trials

View clinical trials related to Pancreas Tumor.

Filter by:
  • None
  • Page 1

NCT ID: NCT05128890 Recruiting - Surgery Clinical Trials

Evaluation of Resection Techniques for Pancreatic Tumors

Start date: April 16, 2016
Phase:
Study type: Observational

The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.

NCT ID: NCT05101772 Recruiting - Pancreas Tumor Clinical Trials

25G and 22G Puncture Needles

Start date: September 24, 2021
Phase:
Study type: Observational

The screened patients were randomly assigned 25G puncture needles and 22G puncture needles in a 1;1 ratio, based on the computer-generated random order, before receiving an ultrasound endoscope puncture. Each puncture needle puncture lesions 2 needles, the same type of puncture needle tissue samples taken in the same tissue pathology bottle, all tissues after the completion of the necessary cytological smears, are placed in the Formalin solution to send tissue pathology, pathologists do not know the order of distribution of 2 puncture needles to evaluate the tissue results, all pathology results are reported by the hospital pathology center, audit.

NCT ID: NCT04707365 Not yet recruiting - Colorectal Cancer Clinical Trials

Microenvironment and Immunity of Digestive Cancers - East Paris Multicentric Cohort

MICADO
Start date: March 2021
Phase: N/A
Study type: Interventional

Colorectal and pancreatobiliary cancers are the most common digestive cancers. Their incidence has particularly increased over the last few decades, leading to suspicion that environmental factors are involved. In addition, strategies for the therapeutic management of these cancers are evolving in the context of the development of immunotherapies. Tumor microenvironment is a potential source of new diagnostic, prognostic and predictive markers and new therapeutic targets. The links between tumor microenvironment and modulation of the immune system in colorectal and pancreatobiliary cancers are poorly understood. Molecular classifications have been proposed for these cancers, but their link with immunity and response to treatment remains to be explored. Objective : explore links between molecular subtypes, tumor microenvironment, host (immune system, pre-metastatic niche, intestinal microbiota, metabolism), and survival (prognostic value), response (predictive value) and tolerance (toxicities) to treatments in digestive cancers, in particular colorectal and pancreatobiliary cancers. Method: Retrospective and prospective monocentric cohort study

NCT ID: NCT01441492 Completed - Pancreatitis Clinical Trials

Pancreas Resection With and Without Drains

Start date: September 2011
Phase: N/A
Study type: Interventional

This randomized prospective trial is designed to test the hypothesis that pancreatectomy without routine intraperitoneal drainage does not increase the severity or frequency of complications within 60 days of surgery.